Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Luca Stirparo
Observed names:
L. Stirparo,
Stirparo L
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
OpenAlex ID:
A5026661663
Role of microRNAs in Chronic Lymphocytic Leukemia
2023
·
Francesco Autore
, Alice Ramassone
, et al.
·
International Journal of Molecular Sciences
·
27
PDF
First‐line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real‐life study on 547 patients to evaluate the long‐term efficacy and tolerability of different chemoimmunotherapy strategies
2024
·
Francesco Autore
, A. Tedeschi
, et al.
·
American Journal of Hematology
·
12
Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review
2021
·
Alberto Fresa
, Francesco Autore
, et al.
·
Journal of Clinical Medicine
·
12
PDF
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed
2024
·
Alberto Fresa
, Idanna Innocenti
, et al.
·
Cancers
·
10
PDF
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid‐19 pandemics
2022
·
Idanna Innocenti
, Annamaria Tomasso
, et al.
·
Hematological Oncology
·
8
PDF
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience
2022
·
Francesco Autore
, Luca Stirparo
, et al.
·
Frontiers in Oncology
·
5
PDF
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real‐life experience
2024
·
Idanna Innocenti
, Antonio Mosca
, et al.
·
HemaSphere
·
4
PDF
Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature
2024
·
Alberto Fresa
, Idanna Innocenti
, et al.
·
Therapeutic Advances in Hematology
·
4
Acalabrutinib in High‐Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real‐Life Experience
2025
·
Idanna Innocenti
, Annamaria Tomasso
, et al.
·
Hematological Oncology
·
3
PDF
Prevention of CINV in Patients with Multiple Myeloma or Lymphoma Undergoing Hematopoietic Stem Cell Transplantation: NEPA Versus Ondansetron. a Monocentric Real-Life Experience
2023
·
Idanna Innocenti
, Annamaria Tomasso
, et al.
·
Blood
·
1
PDF
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study
2022
·
Giulia Benintende
, Idanna Innocenti
, et al.
·
Haematologica
·
1
PDF
A case of Pseudo-Richter Transformation following zanubrutinib discontinuation in CLL
2026
·
Luca Laurenti
, Tommaso Quaranta
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
PDF
No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12
2026
·
Luca Laurenti
, Feliciana Guglielmi
, et al.
·
Blood Advances
Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian study
2026
·
Francesco Autore
, Alessandra Tedeschi
, et al.
·
Blood Advances
PDF
Btkis and DRC show a reduction of infections and need of hospitalization towards BR and other chemo-immunotherapies in waldenstrom macroglobulinemia.
2025
·
Francesco Autore
, Annamaria Frustaci
, et al.
·
Blood
PDF
Absence of lymphocytosis after starting treatment with cbtki is a rare phenomenon except for CD49d positive CLL mainly expressed in trisomy 12.
2025
·
Luca Laurenti
, Feliciana Guglielmi
, et al.
·
Blood
Longitudinal analysis of richter syndrome risk and survival in CLL: The role of targeted therapy and molecular markers. experience at the fondazione policlinico gemelli in rome.
2025
·
Idanna Innocenti
, Tommaso Quaranta
, et al.
·
Blood
Oncogeriatric assessment of patients with chronic lymphatic leukaemia over 65 years old undergoing target therapies: A pilot study conducted at the fondazione policlinico gemelli.
2025
·
Idanna Innocenti
, Giuseppe Ferdinando Colloca
, et al.
·
Blood
PDF
A landscape of genetic heterogeneity in germline predisposition to familial chronic lymphocytic leukemia
2025
·
Luca Laurenti
, Eugenio Sangiorgi
, et al.
·
Research Square
PDF
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study
2025
·
Alberto Fresa
, Idanna Innocenti
, et al.
·
Blood Advances
PDF
Familial Forms of Chronic Lymphocytic Leukemia Have a Worse Prognosis Than Sporadic Forms: an Italian Case-Control Study.
2025
·
Fresa A
, Innocenti I
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
PDF
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience
2024
·
Idanna Innocenti
, Tommaso Quaranta
, et al.
·
Hematological Oncology
PDF
Author response for "Acalabrutinib in High‐Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real‐Life Experience"
2024
·
Idanna Innocenti
, Annamaria Tomasso
, et al.
Author response for "Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience"
2024
·
Idanna Innocenti
, Tommaso Quaranta
, et al.
Ibrutinib or Chemo-Immunotherapy As Second Line Treatment in Waldenstrom Macroglobulinaemia? a Real-Life Multicentre Study
2024
·
Francesco Autore
, Alessandra Tedeschi
, et al.
·
Blood
Show more works
View as search
Works count:
40
Citation count:
87
H-index:
5
I10-index:
4
Year
Topic
Type